Black Diamond Therapeutics, Inc.
BDTX
$3.05
$0.113.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.56M | 56.54M | -15.99M | -15.56M | -19.91M |
| Total Depreciation and Amortization | 86.00K | 87.00K | 85.00K | 86.00K | 86.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.12M | 2.04M | 1.66M | 1.67M | 4.88M |
| Change in Net Operating Assets | -805.00K | -5.26M | -816.00K | 2.48M | 217.00K |
| Cash from Operations | -9.16M | 53.41M | -15.06M | -11.32M | -14.73M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 10.00K | 13.00K | 8.00K | 48.00K | 38.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -59.16M | 8.53M | 27.76M | 2.15M | 702.00K |
| Cash from Investing | -59.15M | 8.55M | 27.77M | 2.19M | 740.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 32.00K | 291.00K | -- | 21.38M |
| Repurchase of Common Stock | -116.00K | -- | -- | -252.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -116.00K | 32.00K | 291.00K | -252.00K | 21.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.43M | 61.99M | 13.01M | -9.38M | 7.39M |